New York State Common Retirement Fund’s GSK GSK Stock Holding History

New York State Common Retirement Fund’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.8M	Sell	245,075 -483,429	-66%	-$25.6M	0.02%	663
2026 Q1	$40.2M	Buy	728,504 +234,019	+47%	+$12.7M	0.06%	245
2025 Q4	$24.2M	Buy	494,485 +397,125	+408%	+$18.5M	0.03%	364
2025 Q3	$4.2M	Buy	97,360 +18,330	+23%	+$716K	0.01%	1141
2025 Q2	$3.03M	Buy	79,030 +52,813	+201%	+$2.02M	﹤0.01%	1261
2025 Q1	$1.02M	Buy	26,217 +22,965	+706%	+$841K	﹤0.01%	1620
2024 Q4	$110K	Sell	3,252 -133,513	-98%	-$4.81M	﹤0.01%	2555
2024 Q3	$5.59M	Buy	136,765 +130,137	+1,963%	+$5.32M	0.01%	1046
2024 Q2	$255K	Sell	6,628 -95,404	-94%	-$4.01M	﹤0.01%	2325
2024 Q1	$4.37M	Buy	102,032 +95,404	+1,439%	+$3.93M	0.01%	1170
2023 Q4	$246K	Hold	6,628	–	–	﹤0.01%	2373
2023 Q3	$240K	Sell	6,628 -204,965	-97%	-$7.27M	﹤0.01%	2347
2023 Q2	$7.54M	Sell	211,593 -80,494	-28%	-$2.89M	0.01%	1000
2023 Q1	$10.4M	Sell	292,087 -13,544	-4%	-$474K	0.01%	856
2022 Q4	$10.7M	Sell	305,631 -112,735	-27%	-$3.76M	0.01%	838
2022 Q3	$12.3M	Buy	418,366 +136,432	+48%	+$5.17M	0.02%	747
2022 Q2	$15.3M	Sell	281,934 -6,176	-2%	-$341K	0.02%	671
2022 Q1	$15.7M	Buy	288,110 +279,742	+3,343%	+$15.2M	0.02%	759
2021 Q4	$461K	Buy	8,368 +1,963	+31%	+$102K	﹤0.01%	2474
2021 Q3	$306K	Buy	+6,405	New	+$322K	﹤0.01%	2713
2021 Q1	–	Sell	-132,604	Closed	-$6.1M	–	3296
2020 Q4	$6.1M	Sell	132,604 -108,226	-45%	-$4.97M	0.01%	1179
2020 Q3	$11.3M	Buy	240,830 +28,080	+13%	+$1.41M	0.01%	793
2020 Q2	$10.8M	Sell	212,750 -76,361	-26%	-$3.92M	0.01%	834
2020 Q1	$13.7M	Buy	289,111 +206,181	+249%	+$11M	0.02%	655
2019 Q4	$4.87M	Buy	82,930 +2,664	+3%	+$148K	0.01%	1262
2019 Q3	$4.28M	Hold	80,266	–	–	0.01%	1301
2019 Q2	$4.01M	Buy	+80,266	New	+$4.03M	0.01%	1345

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

New York State Common Retirement Fund's GSK Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its GSK (GSK) stake by 66% in Q2 2026, selling an estimated $25.6M and leaving 245,075 shares worth $12.8M. The position accounts for 0.02% of the portfolio, ranked #663.

New York State Common Retirement Fund first reported a position in GSK in Q2 2019 and has held it in 27 quarters since. The position peaked at $40.2M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

New York State Common Retirement Fund held 245,075 shares of GSK worth $12.8M as of Q2 2026.
New York State Common Retirement Fund sold 483,429 GSK shares in Q2 2026, an estimated $25.6M.
GSK made up 0.02% of New York State Common Retirement Fund's portfolio in Q2 2026, its #663 holding.
New York State Common Retirement Fund first reported a position in GSK in Q2 2019 and has held it in 27 quarters since.
New York State Common Retirement Fund's GSK position peaked at $40.2M in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.